 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Kimia Biosciences Ltd in their meeting held today i.e. June 19, 2019 has allotted 87,32,000 (Eighty Seven Lacs & Thirty Two Thousand) Equity Shares of Face value of Re.1/- each pursuant to conversion of 8,73,200 Fully Convertible warrants of Face Value of Rs. 10/- each allotted on preferential basis, on Feb 15, 2018, to the person belonging to Promoter & Non-promoter category.
Such warrants were allotted on preferential basis, on Feb 15, 2018, prior to Scheme of Arrangement becoming effective, at a face value of Rs. 10/- each including premium of Rs. 20/- each. However, post Scheme of Arrangement becoming effective(as approved by Hon'ble NCLT vide its order dated Aug 08, 2018), the Face Value of the Equity Shares of the Company has been reduced from Rs 10/- each to Re 1/- each and accordingly, upon conversion of Warrants,each warrants are convertible into 10 (ten) Equity shares of the Face Value of Re. 1/- each, at a premium of Rs. 2/- each.
Post Allotment of 87,32,000 Equity Shares of Face Value of Re. 1/-, the paid-up share capital of the Company shall stand increased to Rs. 2,33,26,421/- comprising of 2,33,26,42] Equity shares of face value of Re. 1/- each.